Phase 3 MDMA trial finds huge potential for treating severe PTSD

The Multidisciplinary Association for Psychedelic Studies (MAPS) has announced the results of a Phase 3 trial involving MDMA-assisted therap...

The Multidisciplinary Association for Psychedelic Studies (MAPS) has announced the results of a Phase 3 trial involving MDMA-assisted therapy for people suffering from chronic and severe PTSD. The results were ‘highly statistically significant,’ according to MAPS, which reports that 67-percent of the participants who underwent three of these MDMA-assisted therapy sessions saw enough improvement that they no longer met the … Continue reading

from SlashGear https://ift.tt/3eCifZO
via IFTTT